MedPath

HSA Approvals

Singapore Health Sciences Authority approved drug registrations and therapeutic product information

Health Sciences Authority
Singapore
5,858 Approvals
Showing 161 to 180 of 5,858 approvalsPage 9 of 293

LOTYRO 150 ERLOTINIB FILM COATED TABLETS 150MG

Approval Number: SIN17080P
Approval: Sep 11, 2024

DIGOKERN TABLETS 0.25MG

Approval Number: SIN17078P
Approval: Sep 10, 2024

PARACOX POWDER FOR SOLUTION FOR INJECTION 40MG/VIAL

Approval Number: SIN17079P
Approval: Sep 10, 2024

CLONAZEPAM MEVON TABLETS 0.5 MG

Approval Number: SIN17075P
Approval: Sep 3, 2024

TELMISARTAN-DRLA TABLETS 80MG

Approval Number: SIN17074P
Approval: Aug 30, 2024

Winlevi Cream 1% w/w

Approval Number: SIN17072P
Approval: Aug 28, 2024

GLYCINORM-MR TABLETS 60 MG

Approval Number: SIN17073P
Approval: Aug 28, 2024

MERO-AFT POWDER FOR INJECTION 1000MG/VIAL

Approval Number: SIN17069P
Approval: Aug 26, 2024

MERO-AFT POWDER FOR INJECTION 500MG/VIAL

Approval Number: SIN17070P
Approval: Aug 26, 2024

EVIPSYZED 25 QUETIAPINE FUMARATE TABLETS USP 25MG

Approval Number: SIN17066P
Approval: Aug 23, 2024

JYNNEOS SUSPENSION FOR INJECTION

Approval Number: SIN17067P
Approval: Aug 23, 2024

NEOPAX FILM-COATED TABLET 400MG

Approval Number: SIN17065P
Approval: Aug 16, 2024

NEOPAX FILM-COATED TABLET 100MG

Approval Number: SIN17064P
Approval: Aug 16, 2024

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.